New Jersey S 2374: Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: S 2374

Sponsors: Bramnick, Jon M., Bucco, Anthony M.

View New Jersey S 2374 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.